Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT03615430 Completed - Breast Cancer Clinical Trials

Serratus Plane Block in Preventing Postoperative Pain of Mastectomy

Start date: June 1, 2016
Phase: N/A
Study type: Interventional

A prospective, double-blinded randomized controlled, 1-year follow-up study was designed to compare the analgesic effect of serratus plane block (SPB) after breast cancer surgery. Women undergoing radical mastectomy were dIvided into Control group and SPB group. The postoperative acute pain was evaluated by numerical rating scale (NRS) and the effect of preventing chronic pain was assessed at 3, 6, 12 months after surgery by NRS.

NCT ID: NCT03612934 Completed - Breast Cancer Clinical Trials

The Impact of SPC on Advanced Breast Cancer Patients

Start date: May 1, 2015
Phase:
Study type: Observational

The aim of this prospective, observational study is the evaluation of the effectiveness of a 14-day Specialist Palliative Care therapy in participants with advanced breast cancer carried out in a stationary palliative care unit in Poland. The length of the entire study will be 36 months.

NCT ID: NCT03604939 Completed - Breast Cancer Clinical Trials

Improving Access to Control of Diseases for Women

IMPACD
Start date: January 1, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the feasibility and acceptability of the model of delivering CHW-driven home-based comprehensive NCD control services aimed to prevent premature deaths from cardio-vascular diseases, stroke and breast, cervix and oral cancers in the hard-to-reach women.

NCT ID: NCT03576521 Completed - Breast Cancer Clinical Trials

Evaluation of Ocoxin®-Viusid® in Breast Cancer

Start date: May 13, 2015
Phase: Phase 2
Study type: Interventional

The purpose is to determine the efficacy of the nutritional supplement Ocoxin-Viusid oral solution (OV) in the reduction of acute toxicity of Chemotherapy (CT) treatment with patients with breast carcinoma. A randomized, double-blind phase II clinical trial was designed, with a sample of 120 patients distributed in 2 arms: 60 patients will receive the CT treatment plus the OV, 60 will receive CT plus OV placebo. The OV / placebo will be administered before, during and 3 weeks after the conclusion of the CT. A better tolerance to the treatment is expected with the addition of the nutritional supplement.

NCT ID: NCT03575520 Completed - Breast Cancer Clinical Trials

Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients

Start date: June 7, 2016
Phase: Phase 2
Study type: Interventional

This is a prospective, single arm study, which is examining doxorubicin and cyclophosphamide (AC) once every 2 weeks with pegteograstim support in Korean early breast cancer.

NCT ID: NCT03546673 Completed - Breast Cancer Clinical Trials

Health Benefits of Expressive Writing: Study One

Komen
Start date: July 2009
Phase: N/A
Study type: Interventional

This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.

NCT ID: NCT03546478 Completed - Breast Cancer Clinical Trials

99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization

Start date: June 24, 2015
Phase: Early Phase 1
Study type: Interventional

This is an open-label single photon emission tomography/computed tomography (SPECT/CT) study to investigate the diagnostic performance and evaluation efficacy of 99mTc-ABH2 in breast cancer patients. A single dose of 370±54 Mega-Becquerel (MBq)99mTc-ABH2 will be injected intravenously. Visual and semiquantitative method will be used to assess the SPECT/CT images.

NCT ID: NCT03541161 Completed - Breast Cancer Clinical Trials

Early Rehabilitation After Immediate Reconstruction With TEI in Breast Cancer Patients

Start date: May 2016
Phase:
Study type: Observational

The purpose of the study is to find best post-operative rehabilitation protocol after total mastectomy and immediate reconstruction with tissue expander insertion. This study compared outcomes of two post-operative rehabilitation protocols ; "conventional protocol", which immobilized shoulder and upper arm motion for a month and "early rehabilitation protocol" with short-term immobilization period and early mobilization.

NCT ID: NCT03530722 Completed - Breast Cancer Clinical Trials

Ex-vivo Performance Evaluation of the Histolog™ Scanner for Human Breast Carcinoma Detection on Fresh Breast Core Biopsies

Start date: July 4, 2017
Phase:
Study type: Observational

Fresh breast core biopsies suspicious for breast cancer that are usually taken during clinical breast assessments will be imaged via confocal microscopy. The device so called HistologTM Scanner is based on confocal fluorescence and displays microscopic histology images superficial layers of fresh tissue. After the imaging procedure the fresh breast tissue specimen will be followed according to the gold standard workflow (H&E-stained images). Subsequently, two pathologists will analyze the HistologTM Scanner obtained-images and H&E-stained images for potential breast cancer structures. A comparison of both analyses for cancer visualization will be performed to evaluate the feasibility of using confocal microscopy for breast cancer detection.

NCT ID: NCT03491917 Completed - Breast Cancer Clinical Trials

Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer

Start date: November 3, 2017
Phase: N/A
Study type: Interventional

The purpose of this pilot is to provide credible performance estimate information in order to conduct a subsequent pivotal reader study.